BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DRD2
,
T cell receptor signaling pathway
,
HIV infection
,
Stem cell
,
DNA fingerprint
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
prkdc protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Potential value of PRKDC as a therapeutic target and prognostic biomarker in pan-cancer.
Up-regulation of PRKDC was associated with poor renal dysfunction after renal transplantation: A mul…
A novel PRKDC mutation caused B lymphocytes V(D)J rearrangement disorder in the SLE-DAH like symptom…
FAP is critical for ovarian cancer cell survival by sustaining NF-κB activation through recruitment …
DNA-PKcs Ser2056 auto-phosphorylation is affected by an O-GlcNAcylation/phosphorylation interplay.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness Genes
Nivolumab and Veliparib in Treating Patients With Recurrent or Refractory Stage IV Solid Tumors That…
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ